Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Tampa, FL
SEC filing record 1 source field available
Fiscal year end
31 December
Akari Therapeutics Plc has filed 729 SEC EDGAR filings since 13 Apr 2012

SEC filing history

Showing 326-350 of 729 matching filings.

Per page
25
Current page
14
D File 021-407386

D filing

Filing date
22 Jul 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36288

FORM 6-K

Filing date
20 Jul 2021
Reporting date
20 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36288

FORM 6-K

Filing date
07 Jul 2021
Reporting date
07 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36288

FORM 6-K

Filing date
02 Jul 2021
Reporting date
01 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36288

FORM 6-K

Filing date
29 Jun 2021
Reporting date
29 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36288

FORM 6-K

Filing date
07 Jun 2021
Reporting date
07 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-233048

EFFECT filing

Filing date
30 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-239923

EFFECT filing

Filing date
30 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-227752

EFFECT filing

Filing date
30 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-234219

EFFECT filing

Filing date
30 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-233048

POS AM

Filing date
28 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36288

FORM 6-K

Filing date
28 Apr 2021
Reporting date
28 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-239923

POS AM

Filing date
28 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-234219

POS AM

Filing date
28 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-227752

POS AM

Filing date
28 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36288

FORM 6-K

Filing date
21 Apr 2021
Reporting date
20 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36288

FORM 6-K

Filing date
12 Apr 2021
Reporting date
12 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36288

FORM 6-K

Filing date
04 Mar 2021
Reporting date
04 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36288

FORM 6-K

Filing date
25 Feb 2021
Reporting date
25 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87614

AMENDMENT NO. 2 TO SCHEDULE 13G

Filing date
16 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36288

FORM 6-K

Filing date
02 Feb 2021
Reporting date
01 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-251673

EFFECT filing

Filing date
31 Dec 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
30 Dec 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
30 Dec 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .